Chromosome 20q Deletion
Authors:
Open Access
- 1 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 135 (3) , 391-397
Abstract
Del(20q) can be observed in hematologic neoplasms, including chronic myelogenous leukemia (CML), and has been reported in patients undergoing blast transformation. We describe 10 patients with CML in hematologic and cytogenetic remission with del(20q) detected by conventional cytogenetics. There were 6 men and 4 women with a median age of 56 years. All patients initially had BCR-ABL1 and t(9;22) (q34;q11.2) and achieved morphologic and cytogenetic remission after therapy. del(20q) was identified before (2/10 [20%]), at the time of (3/10 [30%]), or after (5/10 [50%]) cytogenetic remission and was not associated with morphologic evidence of dysplasia. At last follow-up, no patients had a myelodysplastic syndrome (MDS). Leukocyte and platelet counts were normal; 4 of 10 patients had mild anemia. Nine patients have remained in morphologic and cytogenetic remission with stable del(20q). BCR-ABL1 fusion transcript levels were absent or low (median, 0.01%). Recently, in 1 patient, recurrent CML developed and del(20q) was lost. We conclude that del(20q) in the setting of CML in remission is not predictive of MDS or blast transformation.Keywords
This publication has 17 references indexed in Scilit:
- RQ‐PCR based WT1 expression in comparison to BCR‐ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib‐treated chronic myeloid leukaemiaBritish Journal of Haematology, 2009
- del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemiaCancer Genetics and Cytogenetics, 2009
- t(3;21)(q26;q22) in myeloid leukemiaCancer, 2006
- inv(16)(p13q22) in Chronic Myelogenous Leukemia in Blast PhaseAmerican Journal of Clinical Pathology, 2005
- t(8;21)(q22;q22) in Blast Phase of Chronic Myelogenous LeukemiaAmerican Journal of Clinical Pathology, 2004
- Emergence of clonal cytogenetic abnormalities in Ph−cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majorityBlood, 2003
- Mantle Cell Lymphoma with 8q24 Chromosomal Abnormalities: a Report of 5 Cases with Blastoid FeaturesLaboratory Investigation, 2002
- Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8Leukemia, 2002
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Functional interaction between DNA-PK and c-Abl in response to DNA damageNature, 1997